Summary

Executive Summary

The Global Plasma Protein Therapeutics Market is estimated at USD 25.4 billion in the year 2020. New plasma-derived therapies is the primary driving factor for the global plasma protein therapeutics market.

Increasing introduction of new plasma-derived therapies with increasing use of Plasma Protein Therapeutics in pharmaceuticals, which are effectively used to treat various diseases like hemostasis and growing awareness on the utilization of various components in the laboratories that are highly effective and promote a modernized way of treatment procedures significantly influences the demand of the global Plasma Protein Therapeutics market.

The plasma protein therapeutics market is also driven by rising incidences of genetic disorder diseases worldwide. Moreover, the trends towards detecting the diseases at an early stage by diagnosing as early as possible is enhancing the growth of the market. From the past two decades, the demand for targeted therapies is growing tremendously, which is solely to level up the growth rate of the market. These factors are additionally fuelling the growth of the overall plasma protein market globally.

Furthermore, the market is experiencing a surge in the demand of advanced therapeutic remedies being developed from the plasma protein because of its effective advantages, thereby driving the growth of the market. Furthermore, the government aids toward the advancing healthcare industry and the favorable reimbursement policies by the health policy investment companies also facilitating the growth of the market.

Scope of the Report

• The report presents the analysis of Clear Aligner market for the historical period 2016-2020 and forecast period of 2021-2026.

• The report analyses the Peptides Therapeutic Market by value (USD Million).

• The report analyses the Peptides Therapeutic Market by Product (Immunoglobulin, Albumin, Factor VIII, Others).

• The report analyses the Peptides Therapeutic Market by Application (Hemophilia, PID, ITP, Others).

• The Global Peptides Therapeutic Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA) By Country (United States, Canada, Germany, U.K, France, Spain, China, Japan, Australia and South Korea).

• The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Product, by Application.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Behring, Baxter International Inc., Takeda Pharmaceutical Company Limited, Biotest AG, Bayer Group, Grifols, S.A., Pfizer, OCTA Pharma, Kedrion bio Pharma, ADMA biologics, Inc.

Key Target Audience

• Biotechnology Companies

• Pharmaceutical Companies

• Consulting and Advisory Firms

• Government and Policy Makers

• Regulatory Authorities

ページTOPに戻る

Table of Contents

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Plasma Protein Therapeutics Market: Product Outlook

4. Global Plasma Protein Therapeutics Market: Sizing and Forecast

4.1 Global Plasma Protein Therapeutics Market Size, By Value, Year 2016-2026

5. Global Plasma Protein Therapeutics Market Segmentation - By Product, By Application

5.1 Competitive Scenario of Global Plasma TherapeuticsProtein Therapeutics Market: By Product

5.1.1 Immunoglobulin - Market Size and Forecast (2016-2026)

5.1.2 Albumin - Market Size and Forecast (2016-2026)

5.1.3 Factor VIII  - Market Size and Forecast (2016-2026)

5.1.4 Others  - Market Size and Forecast (2016-2026)

5.2 Competitive Scenario of Global Plasma Protein Market: By Application

5.2.1 Hemophilia  - Market Size and Forecast (2016-2026)

5.2.2 PID (Primary Immunodeficiency Disorder) -  Market Size and Forecast (2016-2026)

5.2.3 ITP (Idiopathic Thrombocytopenic Purpura) - Market Size and Forecast (2016-2026)

5.2.4 Others  Market Size and Forecast (2016-2026)

6. Global Plasma Protein Therapeutics Market: Regional Analysis

6.1 Competitive Scenario of Global Plasma Protein Therapeutics Market : By Region

7. North America Plasma Protein Therapeutics Market: An Analysis (2016-2026)

7.1 North America Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

7.2 North America Plasma Protein Therapeutics Market - Prominent Companies

7.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)   

7.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others) 

7.5 North America Plasma Protein Therapeutics Market: Country Analysis 

7.6 Market Opportunity Chart of North America Plasma Protein Market - By Country, By Value, 2026

7.7 Competitive Scenario of North America Plasma Protein Market: By Country

7.8 United States Plasma Protein Market: Size and Forecast (2016-2026), By Value

7.9 United States Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

7.10 Canada  Plasma Protein Market: Size and Forecast (2016-2026), By Value

7.11 Canada Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

8. Europe Plasma Protein Therapeutics Market: An Analysis (2016-2026)

8.1 Europe Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

8.2 Europe Plasma Protein Therapeutics Market - Prominent Companies

8.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others) 

8.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others) 

8.5 Europe Plasma Protein Market: Country Analysis 

8.6 Market Opportunity Chart of Europe Plasma Protein Market - By Country, By Value, 2026

8.7 Competitive Scenario of Europe Plasma Protein Market: By Country

8.8 Germany Plasma Protein Market: Size and Forecast (2016-2026), By Value

8.9 Germany Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

8.10 United Kingdom Plasma Protein Market: Size and Forecast (2016-2026), By Value

8.11 United Kingdom Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

8.12 France Plasma Protein Market: Size and Forecast (2016-2026), By Value

8.13 France Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

8.14 Spain Plasma Protein Market: Size and Forecast (2016-2026), By Value

8.15 Spain Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

9. Asia Pacific Plasma Protein Therapeutics Market: An Analysis (2016-2026)

9.1 Asia Pacific Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

9.2 Asia Pacific Plasma Protein Therapeutics Market - Prominent Companies

9.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others) 

9.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others) 

9.5 Asia Pacific Plasma Protein Market: Country Analysis 

9.6 Market Opportunity Chart of Asia Pacific Plasma Protein Market - By Country, By Value, 2026

9.7 Competitive Scenario of Asia Pacific Plasma Protein Market: By Country

9.8 China Plasma Protein Market: Size and Forecast (2016-2026), By Value

9.9 China Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

9.10 Japan Plasma Protein Market: Size and Forecast (2016-2026), By Value

9.11 Japan Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

9.12 Australia Plasma Protein Market: Size and Forecast (2016-2026), By Value

9.13 Australia Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

9.14 South Korea Plasma Protein Market: Size and Forecast (2016-2026), By Value

9.15 South Korea Plasma Protein Market Segmentation - By Product, By Application (2016-2026)

10. Global Plasma Protein Therapeutics Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends

11. Market Attractiveness

11.1 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Product, 2026

11.2 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Application, 2026

11.3 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Region, 2026

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

12.2 Product Pipeline of Leading Plasma Protein Companies

12.3 Market Share Analysis

13. Company Analysis

13.1 CSL Behring

13.2 Baxter International Inc.

13.3 Takeda Pharmaceutical Company Limited

13.4 Biotest AG

13.5 Bayer Group

13.6 Grifols, S.A.

13.7 Pfizer

13.8 OCTA Pharma

13.9 Kedrion bio Pharma

13.10 ADMA biologics, Inc.